Evidence map›Paper›PMID 30229909›Full record

ArticleThe Journal of pathology2018

Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.

Kevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, Allison Vitonis, Leona A Doyle, Jason L Hornick, Gurkan Kaya, Laurent Barnes, Daniel W Cramer, Giacomo Puppa and 9 more

Abstract readComparative Study
In one paragraph

Article in The Journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cellular origins of mucinous ovarian carcinoma.The Journal of pathology · 2025
    Review
  9. Article
  10. Review
  11. Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas.Cold Spring Harbor perspectives in medicine · 2023
    Review
  12. Germline stem cells in human.Signal transduction and targeted therapy · 2022
    Review
  13. Article
  14. Article
  15. Early detection of pancreatic cancer using DNA-based molecular approaches.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  16. Article
  17. To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Kevin M EliasDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA.
Petros TsantoulisDepartment of internal medicine specialties, Facutly of Medicine, Université de Genève, Geneva, Switzerland.
Jean-Christophe TilleDivision of Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Allison VitonisDepartment of Obstetrics and Gynecology, Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA.
Leona A DoyleHarvard Medical School, Boston, MA, USA.
Jason L HornickHarvard Medical School, Boston, MA, USA.
Gurkan KayaDepartment of internal medicine specialties, Facutly of Medicine, Université de Genève, Geneva, Switzerland.
Laurent BarnesDivision of Dermatology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Daniel W CramerHarvard Medical School, Boston, MA, USA.
Giacomo PuppaDivision of Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Sarah StuckelbergerPenn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-2675-0120
Jagmohan HoodaPenn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA.
Pierre-Yves DietrichDepartment of internal medicine specialties, Facutly of Medicine, Université de Genève, Geneva, Switzerland.
Michael GogginsDepartment of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.ORCID 0000-0002-4286-2296
Candace L KerrDepartment of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD, USA.
Michael BirrerDivision of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA.
Michelle S HirschHarvard Medical School, Boston, MA, USA.
Ronny DrapkinPenn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-6912-6977
Sana Intidhar Labidi-GalyDepartment of internal medicine specialties, Facutly of Medicine, Université de Genève, Geneva, Switzerland.ORCID 0000-0002-0824-3475
Brigham and Women's Hospital · USUniversity of Geneva · CHCancer Research Center · USHôpital Beau-Séjour · CHJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of Maryland, Baltimore · US

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
NICHD NIH HHS K12 HD000849
6 · The paper itself

Abstract

Mucinous ovarian tumors (MOTs) morphologically and epidemiologically resemble mucinous cystic neoplasms (MCNs) of the pancreas, sharing a similar stroma and both occurring disproportionately among young females. Additionally, MOTs and MCNs share similar clinical characteristics and immunohistochemical phenotypes. Exome sequencing has revealed frequent recurrent mutations in KRAS and RNF43 in both MOTs and MCNs. The cell of origin for these tumors remains unclear, but MOTs sometimes arise in the context of mature cystic teratomas and other primordial germ cell (PGC) tumors. We undertook the present study to investigate whether non-teratoma-associated MOTs and MCNs share a common cell of origin. Comparisons of the gene expression profiles of MOTs [including both the mucinous borderline ovarian tumors (MBOTs) and invasive mucinous ovarian carcinomas (MOCs)], high-grade serous ovarian carcinomas, ovarian surface epithelium, Fallopian tube epithelium, normal pancreatic tissue, pancreatic duct adenocarcinomas, MCNs, and single-cell RNA-sequencing of PGCs revealed that both MOTs and MCNs are more closely related to PGCs than to either eutopic epithelial tumors or normal epithelia. We hypothesize that MCNs may arise from PGCs that stopped in the dorsal pancreas during their descent to the gonads during early human embryogenesis, while MOTs arise from PGCs in the ovary. Together, these data suggest a common pathway for the development of MCNs and MOTs, and suggest that these tumors may be more properly classified as germ cell tumor variants. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Cell LineageAdultComputational BiologyDatabases, GeneticData MiningFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalGerm CellsHumansMaleMiddle AgedMorphogenesisNeoplasms, Cystic, Mucinous, and SerousNeoplasms, Germ Cell and EmbryonalNeoplastic Stem Cellsmucinous cystic neoplasmmucinous ovarian tumorpathogenesisprimordial germ cellsRHOB

Identifiers

PMID30229909
PMCPMC6240919
OpenAlexW2891426600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.